THE USE OF A PROTEIN TYROSINE INHIBITOR SUCH AS GENISTEIN IN THE TREATMENT OF DIABETIC RETINOPATHY OR OCULAR INFLAMMATION

摘要

The present invention is directed to a method for the prophylactic andtherapeutic treatment of diabetic retinopathy and a method forthe prophylactic and therapeutic treatment of ocular inflammation. The methodsinvolve the administration of an inhibitor of the proteintyrosine kinase pathway to an animal, such as a mammal, in particular a human,in an amount sufficient to treat diabetic retinopathy orocular inflammation, respectively, prophylactically or therapeutically. Theinhibitor of the protein tyrosine kinase pathway is preferablygenistein or an analogue or prodrug thereof or a pharmaceutically acceptablesalt of any of the foregoing.